US FDA Lowers FY '22 PDUFA Fees Due to Hiring, Attrition Concerns

The agency reissued the user fee notice, saying fewer dollars were needed for new staff.

Pile of money
Despite a more than 2% reduction, the most expensive PDUFA fee still will be more than $3.1m. • Source: Alamy

The US Food and Drug Administration decided to recalculate fiscal year 2022 prescription drug user fees, sending them lower, because its ability to increase staffing levels has been hurt recently.

After concerns about process misunderstandings, the agency withdrew an earlier version of the fee notice and then reissued it 13...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from Pathways & Standards